NSE filing, NSE: SAMMAANCAP. Summary written from the filing by ALFA Finder's alert engine.
Sammaan Capital Ltd: key numbers
- Share price
- ₹116.04
- Market cap
- ₹13,490 Cr
- Revenue (annual)
- ₹8,166 Cr
- Net profit (annual)
- ₹-7,145 Cr
- P/E (TTM)
- -1.9×Sector 19.7×
- Promoter holding
- 28.34%+0.00% QoQ
- FII holding
- 21.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sammaan Capital Ltd
All →Sammaan Capital Debt & Borrowing: ₹0.06 Cr
Sammaan Capital certified timely monthly interest payments on two listed secured NCD series, totalling about ₹5.73 lakh. The filing confirms servicing of existing debt rather than new borrowing.
- Value
- ₹0.06 Cr
Sammaan Capital Debt & Borrowing: ₹0.11 Cr
Sammaan Capital certified timely payment of ₹10.70 lakh interest on two listed secured NCD series due October 2026. No redemption was made.
- Value
- ₹0.11 Cr
Sammaan Capital Debt & Borrowing: ₹0.08 Cr
Sammaan Capital confirmed timely payment of interest on secured NCDs. Interest paid totals about ₹8.42 lakh, or 0.08 Crore, across two ISINs.
- Value
- ₹0.08 Cr
Sammaan Capital Debt & Borrowing: ₹0.54 Cr
Sammaan Capital certified timely interest payment of about Rs. 0.54 Crore across nine listed secured NCD ISINs on 27 October 2026. No delay or non-payment was reported.
- Value
- ₹0.54 Cr
Sammaan Capital Debt & Borrowing: ₹0.38 Cr
Sammaan Capital certified timely interest payment on six secured NCD series. Total interest paid is about Rs.0.38 Crore.
- Value
- ₹0.38 Cr
Sammaan Capital Debt & Borrowing: ₹0.02 Cr
Sammaan Capital certified timely interest payment on its secured NCDs for two ISINs. Interest paid totals about Rs.0.02 Crore.
- Value
- ₹0.02 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date